Infectious disease. A sustainable model for antibiotics.
AstraZeneca Innovative Medicines and Early Development, Gatehouse Drive, Waltham, MA 02451, USA. manos.perros@astrazeneca.com.
Manos
M
Perros
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D015780:Carbapenems / Q000737:chemistry / Q000494:pharmacology; D055808:Drug Discovery; D024881:Drug Resistance, Bacterial; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D057285:Precision Medicine; D054852:Small Molecule Libraries; D018440:beta-Lactam Resistance
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D054852:Small Molecule Libraries